Purchase Order 75N90024P00366
Award Date 4/26/24
Potential Completion Date 5/27/24
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency under the U.S. Department of Health and Human Services, to Sirion Biotech GmbH, a foreign-owned for-profit organization. The $21,966.56 contract provides LENTIBOOST formulated, Good Manufacturing Practice (GMP)-grade lentiviral products and other viral vector reagents from Sirion Biotech's facilities in Germany. These specialized reagents support gene therapy research...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed price purchase order to Sirion Biotech GmbH, a foreign-owned for-profit organization, for the delivery of LENTIBOOST formulated, GMP-grade viral vector products. The order, valued at $21,000.00, supported gene therapy research and patient treatments conducted by the NIH Clinical Center. The contract did not have any set-aside designations and Sirion Biotech delivered the requested viral...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of Acquisitions awarded a $103,508.51 purchase order to Trenzyme GmbH of Bethesda, Maryland. The contract calls for the prime contractor to perform PCR-amplification and cloning of a tet-on inducible exoin-C/E3/E2/6K/E1 vector to support the agency's biomedical research efforts. Work will be conducted in Bethesda through January 18, 2010 under a fixed price...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $202,000.00 firm fixed price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for the "SIRNAS WITH ACCELL MODIFICATION PROJECT". The contract, which does not have a small business set-aside, is for the provision of various gene silencing and regulation products, including small interfering...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a firm fixed-price purchase order to Omixon, Inc., a foreign-owned for-profit organization, to provide reagents in support of the NIH Clinical Center's research and development activities related to HLA testing and transplantation. The contract, valued at $101,220.00, did not utilize any set-aside programs. Omixon, as the prime contractor, has previously provided the NIH Clinical Center with...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $1,722,610.45 firm-fixed-price delivery order contract to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products and services. The contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation instruments. These reagents and kits are used by the NIH Clinical...
- The National Institutes of Health (NIH) awarded a firm fixed-price purchase order valued at $30,000 for scientific studies to be performed in Germany. The contract, awarded on November 19, 2003, was not issued under any set-aside program and carried an ultimate completion date of September 30, 2004. This purchase order structure indicates a straightforward procurement mechanism for defined scientific work, likely supporting NIH's research mission through international collaboration or data...
- The National Institutes of Health (NIH) Clinical Center awarded a Firm Fixed Price Purchase Order contract worth $138,390.00 to Cellgenix USA, a division of Cellgenix GMBH. The contract is for the delivery of specialized cell therapy-related pharmaceuticals such as FLT-3L, SCF, TPO, GM-CSF, and interleukin-4 to support cell and gene therapy research and development at the NIH. Cellgenix USA has provided similar products to the NIH and the National Institute of Allergy and Infectious Diseases...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $198,597.49 firm-fixed-price purchase order contract to Life Technologies Corporation, a for-profit manufacturer, to supply specialized reagents and disposables to support the NIH's cellular therapy research and treatment programs. The contract is for a base year with three option years, providing reagents and supplies to enable the processing of approximately 100 cellular therapy...